DE ARK
Holdings
own 2025 accountsThis companyDE ARK3 holdings, 1 country
2025 accounts
Belgium 3 Equity Result
- BE Klinisch Laboratorium Maenhout €4.0m result €384,582
- BE Medisch Laboratoriumno longer active €778,190 result €385,230
- BE LabCare Plus €327,026 result €62,572
Source: list of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.
Holdings and subsidiaries
3 holdingsHoldings 3
Share, source and own figures per holding (3)
Source for every holding own accounts 2025
- Klinisch Laboratorium MaenhoutsubsidiaryEquity €4.0m Profit of €384,582 in 2025 (profit of €299,784 in 2024) Checked score 93100%
- LabCare PlussubsidiaryEquity €327,026 Profit of €62,572 in 2025 (profit of €15,218 in 2024) Checked score 96100%
- MEDISCH LABORATORIUMsubsidiaryEquity €778,190 Profit of €385,230 in 2025 (loss of €228,673 in 2024)100%
Holdings through the years 2020 to 2025
| Name | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Klinisch Laboratorium Maenhout | 100% | |||||
| LabCare Plus | 100% | |||||
| MEDISCH LABORATORIUM | 100% | |||||
Source: list of holdings in its own accounts
Board mandates elsewhere
2 board mandatesBoard mandates of DE ARKDE ARK sits on their board2
Connections & network
1 current directorThe board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.